Remove 2015 Remove Chemotherapy Remove Pharmaceutical Companies
article thumbnail

2nd Hit ID Summit

pharmaphorum

Skip to main content Friday 18 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

article thumbnail

Country focus: China & APAC’s growing medical needs bring opportunities and challenges

pharmaphorum

At the same time, lots of people with experience at multinational pharmaceutical companies have chosen to return home. All these factors will support the growth of in-house R&D-driven pharmaceutical companies and bring more innovative drugs to Asian markets.”. Chemotherapy still accounted for 72.6%

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The new pharma collaborations driving transformative research in oncology

pharmaphorum

One powerful example is The National Institutes of Health’s Partnership for Accelerating Cancer Therapies (PACT) , which brought together 11 pharmaceutical companies to accelerate the development of new cancer immunotherapies. Case Study: From Technology Agreement to co-development and co-commercialisation partnership.

article thumbnail

Advancing microbiome innovation

European Pharmaceutical Review

4 Notably, microbiome therapies have strong potential in onco-haematology, where antibiotic and chemotherapy-derived loss of gut diversity is predictive of mortality in patients who have undergone an allogeneic haematopoietic stem cell transplant, as well as GvHD occurrence and infection. eClinicalMedicine. 2023; 62:102111.

article thumbnail

Amgen's Five Prime takeover delivers gastric cancer win

pharmaphorum

billion, Amgen has promising phase 3 results with a drug for gastric cancer that was the focal point for the deal. billion, Amgen has promising phase 3 results with a drug for gastric cancer that was the focal point for the deal. billion, Amgen has promising phase 3 results with a drug for gastric cancer that was the focal point for the deal.

article thumbnail

Beating the Big C

Pharmaceutical Technology

The world’s biggest pharmaceutical company Pfizer announced in June 2008 that it would be putting its “full scope and scale” behind a push into the cancer market. Analysts predict Pfizer’s revenue stream would be slashed by 25% by 2015 if the company did not branch out into other areas.

article thumbnail

2022 ISPE Annual Meeting & Expo Opening Keynotes Focus on Quality, Transformation, and Patients

ISPE

CDER and OPQ (established in 2015) focuses on quality throughout the produce life cycle, but it faces the challenge of the global nature of the industry, he said: over three quarters of API sites are outside the US; over half of finished drug formulation sites are outside the US. FDA Activities in Support of Quality. Next Slide ??.

FDA